Migraine Trial, Recruiting NCT07354126 Sponsor: Muhammad Aamir Latif Condition: Migraine
Back to Migraine

Migraine Trial, Recruiting

NCT07354126
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children of any gender
  • Children aged between 8 and 15 years old
  • Children who have been diagnosed with migraine (with or without visual or sensory warning signs before the headache) according to recognised international diagnostic guidelines
  • Children who have had at least 4 migraine attacks per month over the past 3 months
  • Children whose migraines have a moderate-to-severe impact on daily life, as measured by a standard questionnaire used for young people (called the PedMIDAS score)

Who may not be able to join:

  • Children whose headaches are caused by another underlying condition, such as an infection, a head injury, or a structural problem in the brain
  • Children who have a known allergy or medical reason that prevents them from taking either of the study medications (flunarizine or propranolol)
  • Children who have certain heart or circulatory conditions, such as a slow heart rate, problems with heart rhythm, low blood pressure, or asthma
  • Children who may have difficulty following the study schedule or attending regular check-up appointments
  • Children who have taken part in another clinical trial within the past 3 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ishafaq Ahmed, FCPS, The Children's Hospital Lahore

Phone: +923334957171

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Muhammad Aamir Latif
Registry
ClinicalTrials.gov
Start date
1 September 2025
Est. completion
28 February 2026

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

Reduction in migraine disability

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov